Overview Financials News + Filings Key Docs Charts Holdings Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Inv. presentation
Quarterly results
Director departure
CC transcript
|
|
Pernix Sleep, Inc. (SOMX)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 05/17/2012 |
8-K/A
| Entry into a Material Definitive Agreement, Financial Statements and Exhibits|
Docs:
|
"LICENSE AGREEMENT DATED AS OF APRIL 26, 2012 BY AND BETWEEN SOMAXON PHARMACEUTICALS, INC. AND CJ CHEILJEDANG CORPORATION LICENSE AGREEMENT THIS LICENSE AGREEMENT is made as of April 26, 2012 , by and between Somaxon Pharmaceuticals, Inc., a Delaware corporation, having a place of business at 10935 Vista Sorrento Parkway, Suite 250, San Diego, California 92130, USA , and CJ CheilJedang Corporation, a corporation duly incorporated under the laws of the Republic of Korea with its registered address at CJ Cheiljedang Center, 330, Dongho-ro, Jung-gu, Seoul, 100-400, Korea . Somaxon and Licensee may hereinafter be referred to individually as a “Party” or collectively as the “Parties.” WHEREAS, Licensee desires to license from Somaxon and Somaxon desires to license to Licensee, on an exclusive ba..." |
|
| 02/11/2011 |
8-K/A
| Form 8-K - Current report [amend] |
| 07/21/2010 |
8-K/A
| Form 8-K - Current report [amend] |
| 06/29/2006 |
8-K/A
| Entry into a Material Definitive Agreement, Financial Statements and Exhibits |
|
|